Expression of Prostanoid EP3 Receptors in Oral Squamous Epithelium and Oral Squamous Cell Carcinoma
Authors:
Open Access
- 9 February 2015
- journal article
- research article
- Published by Wiley in Pathology Research International
- Vol. 2015, 1-7
Abstract
Objectives. To carry out a descriptive analysis of the expression of the EP3 receptors of PGE2 in different histological grades of OSCC and adjacent normal epithelium. Material and Methods. A total of 46 patients presenting with various histological subtypes and grades of OSCC were recruited from Maxillofacial Surgery Department of Nishtar Institute of Dentistry Multan. Microscopically tumour subtyping and histological grading according to Anneroth’s grading system were carried out. Immunohistochemical staining with rabbit polyclonal EP3 receptor antibody was performed and sections were scored for intensity and proportion of positive adjacent squamous epithelial and tumour cells. Results. Out of 46 patients (60.9%) were well differentiated, (32.6%) were moderately differentiated, and only (6.5%) were poorly differentiated. All cases of OSCC were positive for EP3 receptor antibody, (30.4%) cases had strong intensity of anti EP3 antibody staining in tumour tissue, (37%) cases showed moderate intensity, and (32.6%) cases showed weak intensity. Conclusion. Prostanoid EP3 receptors are widely but variably expressed in OSCC. Most of well differentiated OSCC cases show a moderate to strong expression of EP3 receptors. However, insignificant statistical relation to histological grades of OSCC has been observed. This might be due to small sample size of the study.
Keywords
This publication has 23 references indexed in Scilit:
- Stromal features are predictive of disease mortality in oral cancer patientsThe Journal of Pathology, 2011
- Oral cancer: Clinical featuresOral Oncology, 2010
- Oral squamous cell carcinoma overviewOral Oncology, 2009
- Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral PremalignancyJournal of Clinical Oncology, 2009
- Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancerHead & Neck, 2008
- Aspirin and the Prevention of Colorectal CancerNew England Journal of Medicine, 2003
- Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2Nature Reviews Cancer, 2001
- Prostanoid Receptors: Structures, Properties, and FunctionsPhysiological Reviews, 1999
- Genetic progression model for head and neck cancer: implications for field cancerization.1996
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991